Catch the Latest Buzz: Weekly News Release Highlights

$BSEM BioStem Technologies (OTCQB: BSEM) (@BSEM_Tech) / X BioStem Technologies, Inc. has announced that it will unveil its financial results for the second quarter of 2024 after the market closes on Monday, August 12, 2024. The company will conduct a conference call and webcast at 4:30 PM ET to review the outcomes. During the webcast, Jason Matuszewski, the CEO, and Michael Fortunato, the CFO, will provide an overview of the quarter.

$VHAI Vocodia (@TheVocodia) / X Vocodia Holdings Corp., a prominent player in AI software development focused on practical applications of artificial intelligence, has recently announced the completion of a Securities Purchase Agreement (referred to as the "SPA") and a Placement Agency Agreement. These agreements represent a significant milestone in Vocodia's strategic growth efforts and optimization of its capital structure.

$OCX Oncocyte (@OncocyteCorp) / X Oncocyte Corp., a firm specializing in molecular diagnostics technology, has revealed that its Chief Executive Officer, Josh Riggs, and Chief Financial Officer, Andrea James, will participate in two upcoming investor conventions in August. These gatherings consist of the 9th Annual Needham Virtual MedTech & Diagnostics 1×1 Conference happening from August 12-13, 2024, and the Sidoti Micro-Cap Virtual Conference scheduled for August 14-15, 2024.

$RMSL Remsleep Holdings Inc (@RemsleepInc) / X REMSleep Holdings, Inc., a trailblazer in the development of state-of-the-art products for sleep apnea, has released a corporate letter to its investors. In it, the company reveals its ambitious aim to seize a 10% market share in the CPAP Mask Market within the next 24 months.

$AMS American Shared Hospital Services has expanded its reach to provide advanced medical services in Mexico by launching patient treatments at its Radiation Therapy Facility, A.B. Radiocirugía y Radioterapia de Puebla in Puebla, Mexico. This strategic facility aims to meet the growing demand for specialized healthcare services in the region. Equipped with state-of-the-art technology and staffed by experienced medical professionals, the facility ensures high-quality care for every patient. AMS's commitment to excellence is evident in the meticulous planning and execution of the Radiation Therapy Facility, following stringent safety protocols and quality standards.

$AAGC @HStarcuts Hollywood Star Cuts has expanded its reach through a strategic partnership with a haircare franchise group based in Utah. The agreement, finalized on August 5th, 2024, involves a group that owns and manages twelve full-service family hair salons under a well-known franchise brand. Over the weekend, representatives from the Utah group visited Hollywood Star Cuts facilities in Boise, Idaho, to gain a comprehensive understanding of the business model and franchise opportunities available.

$SKYX @skyxplatforms SKYX Announces Corporate Update Call - Company to Provide Corporate Updates Including Second Quarter 2024 Financial Results; Conference Call to be Held on Monday, August 12, 2024 at 4:30 PM Eastern Time.

$BCDS @BlaqcloudsBCDS BLAQclouds, Inc. announced its plans to acquire the equity of ZEUS Blockchain Partners, Inc. through a SAFE Agreement. This acquisition process grants BLAQclouds, Inc. a 90-day exclusive window to finalize the transaction.

$WENA ANEW MEDICAL, INC., a US-based biotechnology company focused on developing cell- and gene-based treatments to affect aging and age-related diseases, announces the grant and issuance of patent number HK1259628 protecting the development of novel genetic approaches for the treatment of neurodegenerative diseases to include Alzheimer’s disease, Parkinson’s diseases and amyotrophic lateral sclerosis (“ALS”).

$BIEI @PremierGraphene Premier Graphene, Inc. disclosed that a leading material handling enterprise invited Premier Graphene to test and validate HGI's exclusive hemp-derived graphene compound in concrete. This formulation, under distribution rights in the United States, exhibited a remarkable 32% enhancement in tensile strength according to the initial engineering assessment conducted by Baja California Test S.A. de R.L. de C.V. Impressed by these findings, the primary materials handling, production, and manufacturing corporation is currently conducting independent evaluations to corroborate the previously reported results.

$OCX @OncocyteCorp Oncocyte Announces Successful GraftAssure Beta Launch and Q2 2024 Results - Interest in kidney transplant assay represents approximately 25% of US transplant volume - Company lays out land and expand strategy in transplant

$WENA ANEW MEDICAL, INC. has revealed its plans to advance the development of treatments utilizing unique peptides that specifically target and stimulate melanocortin receptors on nerve cells in the brain. These receptors, including melanocortin-3 and melanocortin-4, play a crucial role in regulating eating disorders and obesity. This initiative stems from a global licensing agreement with Teleost Biopharmaceuticals and the University of Arizona, highlighting the significance of understanding the neurobiology behind overeating and obesity